|
⚲
|
| Keyboard |
| Paladin Capital LLC
✚
|
|
|---|---|
| CRD # | 288037 |
| SEC # | 801-128690 |
| CIK # | 0001788497 |
| AUM | 10.0 M (2026-06-24) |
| Employees | 5 (80% Investors, 80% Brokers) |
| Fees | |
| Minimum | |
| Phone | 651-842-8406 |
| Address | 4105 Lexington Avenue North Arden Hills, MN 55126 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 18 | 7.9 |
| (b) Individuals (high net worth individuals) | 1 | 2.1 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 52 | 10.0 |
| By Discretionary | ||
| Discretionary | 52 | 10.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 52 | 10.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 10.0 | |
| Total | 52 | 10.0 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001788497] | |
| 4 | [0001788497] | |
| SC 13G | [0001788497] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Paladin Capital Management LLC | 10X Genomics Inc | [2020-02-18] |
| Firm Profile (Form ADV) | |
|---|---|
| Clients | 1 |
| Serves | Institutional, Retail |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-04-30 | Sell | 1,000,000 | $78.25 | 78,250,000 |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-04-21 | Sell | 568 | $74.48 | 42,305 |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-03-17 | Other | 1,527,241 | $0.00 | |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-03-16 | Other | 619,306 | $0.00 | |
|
10x Genomics Inc TXG
Class A Common Stock
|
2020-02-20 | Conversion | 8,675,167 | ||
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2020-02-20 | Conversion | 8,675,167 | ||
|
10x Genomics Inc TXG
Series A-1 Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 790,487 | $0.00 | |
|
10x Genomics Inc TXG
Series D Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 653,082 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 790,487 | $0.00 | |
|
10x Genomics Inc TXG
Series B Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 2,476,963 | $0.00 | |
|
10x Genomics Inc TXG
Series A-2 Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 3,749,767 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 1,004,868 | $0.00 | |
|
10x Genomics Inc TXG
Series C Convertible Preferred Stock · derivative
|
2019-09-16 | Conversion | 1,004,868 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 2,476,963 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 653,082 | $0.00 | |
|
10x Genomics Inc TXG
Class B Common Stock · derivative
|
2019-09-16 | Conversion | 3,749,767 | $0.00 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Portfolio Thinktank
✚
|
10.6 M | |
|
Tinderwealth LLC
✚
|
10.0 M | |
|
Empiric Institutional LLC
✚
|
TX | 9.9 M |
|
Vector Asset Management LLC
✚
|
9.5 M | |
|
Alveo Wealth Management LLC
✚
|
9.4 M | |
|
Virgo Digital Asset Management Inc
✚
|
9.4 M | |
|
Maney Wealth LLC
✚
|
CA | 9.4 M |
|
Journey Equity Wealth Management LLC
✚
|
CA | 9.2 M |
|
Pecusavvy Financial LLC
✚
|
TX | 9.1 M |
|
Concreit Fund Management LLC
✚
|
WA | 9.0 M |